抗がん剤を腫瘍に直接送達するナノ粒子の大量製造法を開発(Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors)

ad

2025-04-03 マサチューセッツ工科大学 (MIT)

マサチューセッツ工科大学(MIT)の研究者たちは、がん治療薬を腫瘍に直接届けるナノ粒子を大量生産する新しい手法を開発しました。従来のレイヤー・バイ・レイヤー(LbL)組み立て技術では、各層の適用後に遠心分離による精製が必要で、大量生産には時間とコストがかかっていました。新手法では、マイクロ流体デバイスを用いて、ナノ粒子が微小なチャネルを流れる際に順次ポリマー層を追加します。これにより、各層の適用後の精製が不要となり、生産効率が大幅に向上しました。この技術は、特に卵巣がんの治療において有望であり、ナノ粒子の臨床応用への道を拓くと期待されています。

<関連情報>

マイクロ流体を介した高スループットの層状ナノ粒子の組み立て High-Throughput Microfluidic-Mediated Assembly of Layer-By-Layer Nanoparticles

Ivan S. Pires, Ezra Gordon, Heikyung Suh, Darrell J. Irvine, Paula T. Hammond
Advanced Functional Materials  Published: 03 April 2025
DOI:https://doi.org/10.1002/adfm.202503965

抗がん剤を腫瘍に直接送達するナノ粒子の大量製造法を開発(Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors)

Abstract

Surface modification of nanoparticles (NPs) via the layer-by-layer (LbL) technique is a promising approach to generate targeted drug delivery vehicles. LbL-NPs have been successfully used in preclinical models for controlled drug release, tumor and immune cell targeting, improved pharmacokinetics and biodistribution, and controlling cellular trafficking and uptake mechanisms. A simple and scalable synthesis method for LbL-NPs that can be adapted for clinical translation is of great interest. Here a new method of polymer deposition is presented onto NPs enabled through microfluidic (MCF) mixing. NPs are mixed with polyelectrolytes using commercially available bifurcating mixer MCF cartridges. In addition to increased process robustness, MCF allows for LbL electrostatic assembly using titrated polymer-to-NP weight equivalent ratios where no excess polymer is required to achieve a given LbL layering. Under such conditions, no time-consuming purification is needed, greatly increasing LbL-NP throughput and avoiding the loss of NPs during purification. The utility of this system is demonstrated using interleukin-12-loaded liposomal NPs, which show equivalent efficacy in vitro and in vivo to LbL-NPs generated via traditional lab-scale batch-wise polymer adsorption and tangential flow filtration purification. Moreover, it is shown that MCF can assemble LbL films of various chemistries and on various NP core substrates.

有機化学・薬学
ad
ad
Follow
ad
タイトルとURLをコピーしました